Arecor Therapeutics (LSE:AREC) Forward Dividend Yield % : 0.00% (As of Jun. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics Forward Dividend Yield %?

As of today (2024-06-14), the Forward Annual Dividend Yield of Arecor Therapeutics is 0.00%.

As of today (2024-06-14), the Trailing Annual Dividend Yield of Arecor Therapeutics is 0.00%.

LSE:AREC's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.655
* Ranked among companies with meaningful Forward Dividend Yield % only.

Arecor Therapeutics's Dividends per Share for the six months ended in Dec. 2023 was £0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Arecor Therapeutics's Forward Dividend Yield %

For the Biotechnology subindustry, Arecor Therapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's Forward Dividend Yield % falls into.

Arecor Therapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Arecor Therapeutics (LSE:AREC) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Arecor Therapeutics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics (LSE:AREC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.